Drug Type AAV based gene therapy |
Synonyms OPGx CNGB1 |
Target |
Mechanism CNGB1 inhibitors(cyclic nucleotide gated channel subunit beta 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Retinitis Pigmentosa | Preclinical | US | 14 Jun 2024 |